These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11241787)

  • 1. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.
    Krauter J; Hoellge W; Wattjes MP; Nagel S; Heidenreich O; Bunjes D; Ganser A; Heil G
    Genes Chromosomes Cancer; 2001 Apr; 30(4):342-8. PubMed ID: 11241787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
    J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
    Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
    Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz MA
    Haematologica; 2000 Jul; 85(7):699-703. PubMed ID: 10897121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
    Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
    Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
    Martinelli G; Rondoni M; Buonamici S; Ottaviani E; Piccaluga PP; Malagola M; Baccarani M
    Haematologica; 2004 Apr; 89(4):495-7. PubMed ID: 15075086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemia.
    Van der Reijden BA; Massop M; Simons A; de Witte T; Breuning M; Jansen JH
    Leukemia; 2010 Apr; 24(4):857-9. PubMed ID: 20072148
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits.
    Park TS; Lee ST; Song J; Lee KA; Lee JH; Kim J; Lee HJ; Han JH; Kim JK; Cho SR; Choi JR
    Cancer Genet Cytogenet; 2009 Mar; 189(2):87-92. PubMed ID: 19215788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.
    van der Reijden BA; Simons A; Luiten E; van der Poel SC; Hogenbirk PE; Tönnissen E; Valk PJ; Löwenberg B; De Greef GE; Breuning MH; Jansen JH
    Br J Haematol; 2002 Aug; 118(2):411-8. PubMed ID: 12139724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
    Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
    Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
    Fujieda A; Nishii K; Tamaru T; Otsuki S; Kobayashi K; Monma F; Ohishi K; Nakase K; Katayama N; Shiku H
    Leuk Res; 2006 Aug; 30(8):1053-7. PubMed ID: 16504290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells.
    Liu PP; Wijmenga C; Hajra A; Blake TB; Kelley CA; Adelstein RS; Bagg A; Rector J; Cotelingam J; Willman CL; Collins FS
    Genes Chromosomes Cancer; 1996 Jun; 16(2):77-87. PubMed ID: 8818654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts.
    Takenokuchi M; Yasuda C; Takeuchi K; Nakamachi Y; Mukai M; Kondo S; Kumagai S; Saigo K; Murayama T; Koizumi T; Tatsumi E
    Clin Lab Haematol; 2004 Apr; 26(2):107-14. PubMed ID: 15053804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
    Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of CBF beta-MYH11 fusion transcript and inv(16)(p13;q22) in acute myelomonocytic leukemia(M4) by RT-PCR and FISH].
    He K; Gu B; Cao Q
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):23-6. PubMed ID: 10921098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts.
    van der Reijden BA; Lombardo M; Dauwerse HG; Giles RH; Mühlematter D; Bellomo MJ; Wessels HW; Beverstock GC; van Ommen GJ; Hagemeijer A
    Blood; 1995 Jul; 86(1):277-82. PubMed ID: 7795233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia.
    Boeckx N; van der Velden VH; Boogaerts M; Hagemeijer A; Vandenberghe P; van Dongen JJ
    Haematologica; 2004 Aug; 89(8):ECR28. PubMed ID: 15339697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of expression of inversion 16 chromosomal fusion transcript CBFB/MYH11 in acute myelogenous leukemia subtype M1 with abnormal bone marrow eosinophilia.
    Monahan BP; Rector JT; Liu PP; Cotelingam JD; Dahut W
    Leukemia; 1996 Oct; 10(10):1653-4. PubMed ID: 8847901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
    Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
    Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.